Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · S

S. 2354 (109th)

Medicare Prescription Drug Gap Reduction Act of 2006

referredUnited States· United States Congress· EN

Introduced

2 March 2006

Last action

2 March 2006 · Introduced

Status

Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S1645-1646)

Sponsors

Sen. Nelson, Bill [D-FL], Sen. Collins, Susan M. [R-ME], Sen. Rockefeller, John D., IV [D-WV], Sen. Boxer, Barbara [D-CA], Sen. Kerry, John F. [D-MA], Sen. Mikulski, Barbara A. [D-MD], Sen. Feingold, Russell D. [D-WI], Sen. Dorgan, Byron L. [D-ND], Sen. Kohl, Herb [D-WI], Sen. Johnson, Tim [D-SD], Sen. Schumer, Charles E. [D-NY], Sen. Clinton, Hillary Rodham [D-NY], Sen. Lautenberg, Frank R. [D-NJ], Sen. Harkin, Tom [D-IA], Sen. Salazar, Ken [D-CO], Sen. Lieberman, Joseph I. [ID-CT], Sen. Cantwell, Maria [D-WA], Sen. Sarbanes, Paul S. [D-MD], Sen. Pryor, Mark L. [D-AR]

Subjects

Healthcare

Source updated

15 August 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Medicare Prescription Drug Gap Reduction Act of 2006 - Amends title XVIII (Medicare) of the Social Security Act (SSA) to reduce the coverage gap in prescription drug coverage under SSA part D (Voluntary Prescription Drug Benefit Program), based on savings to the Medicare program resulting from the negotiation of prescription drug prices. Grants the Secretary of Health and Human Services authority similar to that of other federal entities that purchase prescription drugs in bulk to negotiate contracts with manufacturers of covered part D drugs. States that the Secretary shall be required to: (1) negotiate contracts with manufacturers of covered part D drugs for each fallback prescription drug plan; and (2) participate in negotiation of contracts of any covered part D drug upon request of an approved prescription drug plan or Medicare Advantage Prescription Drug Plan. Prohibits the Secretary from requiring a particular formulary or instituting a price structure for the reimbursement of covered part D drugs in order to carry out, and promote competition, under part D.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 2 March 2006

    Introduced

    Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S1645-1646)

    Source: IntroReferral

  2. 2 March 2006

    Introduced

    Sponsor introductory remarks on measure. (CR S1645)

    Source: IntroReferral

  3. 2 March 2006

    Introduced

    Introduced in Senate

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate (text)

    Introduced in Senate · EN · 2 March 2006

    ViewDownloadOpen at official source

  • Introduced in Senate (PDF)

    Introduced in Senate · EN · 2 March 2006

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate

    summary · EN · 2 March 2006

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.